Stanford University

Running trials

• Not yet recruiting

  Insul-In This Together: Leveraging Family Support and Diabetes Technology for Adolescents Living With Type 1 Diabetes

  NCT07856836· Stanford University· Source

• Not yet recruiting

  Prenatal Transplantation for Fetuses With Fanconi Anemia

  NCT07408583· Phase 1/2· Agnieszka Czechowicz· Source

• Not yet recruiting

  The Effects of Cannabis on Post Operative Recovery After Radical Cystectomy

  NCT07577999· Early phase 1· Stanford University· Source

• Not yet recruiting

  Vagus Nerve Stimulation to Enhance Memory in Aging

  NCT07214194· Stanford University· Source

• Not yet recruiting

  Trial of Center-Based Early Start Denver Model vs. Pivotal Response Treatment in Children With Autism

  NCT07522190· Stanford University· Source

• Recruiting

  Stanford Healthy Goals Study

  NCT07839832· Stanford University· Source

• Not yet recruiting

  Clinical Trial Evaluating the Effects of Ganaxolone in Children With Autism

  NCT07635862· Phase 2· Stanford University· Source

• Not yet recruiting

  Hyaluronidase Injections for Sclerodactyly in Patients With Scleroderma

  NCT07916324· Phase 2· Stanford University· Source

• Enrolling by invitation

  Automated Text Message Reminders to Promote Hearing Aid Adoption

  NCT07170423· Stanford University· Source

• Not yet recruiting

  Modality Choice Before and After Failure for the Treatment of Painful Diabetic Neuropathy

  NCT07795593· Phase 4· University of Michigan· Source

• Not yet recruiting

  Automated Total Marrow and Lymphoid Irradiation for Allogeneic Hematopoietic Cell Transplant

  NCT07634536· Phase 2· Stanford University· Source

• Not yet recruiting

  Alpha-synuclein Education and Disclosure in Individuals With Preclinical and Symptomatic Lewy Body Disease

  NCT07646652· Stanford University· Source

• Recruiting

  Animated Storytelling to Promote Colorectal Cancer Screening

  NCT07522177· Stanford University· Source

• Recruiting

  Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes

  NCT07864168· Medtronic MiniMed, Inc.· Source

• Not yet recruiting

  Empowered Relief for Caregivers

  NCT07636980· Stanford University· Source

• Not yet recruiting

  Smartphone Application to PREDICT Real-Time Cardiovascular Risk for Heart Attack and Stroke

  NCT07735338· Stanford University· Source

• Recruiting

  Ultrasonic Debris Clearance to Promote Brain Resilience

  NCT07573982· Stanford University· Source

• Not yet recruiting

  Using a Personalized Decision Support Tool to Help People With Type 1 Diabetes Manage Exercise

  NCT07226583· Stanford University· Source

• Not yet recruiting

  High-Resolution Measurements of Diet-Microbiome Interactions

  NCT07856823· Stanford University· Source

• Not yet recruiting

  Cilostazol for Prevention of Recurrent Stroke Trial

  NCT07174414· Phase 3· Stanford University· Source

• Recruiting

  CAR-T ceLL for Eradication of Active Residual Disease in LBCL (CLEAR-1 Study)

  NCT07443137· Phase 1· Stanford University· Source

• Not yet recruiting

  Smartshoes for Freezing of Gait in Parkinson's Disease

  NCT07001072· Stanford University· Source

• Not yet recruiting

  Single Arm Intervention Trial of DEKA TWIIST TM Insulin Pump Utilizing Tidepool Loop Algorithm in Pregnant People With Pre-existing Type 1 Diabetes

  NCT07808385· Mayo Clinic· Source

• Not yet recruiting

  Double-Blind Trial of Everolimus for Improving Social Abilities in PTEN Germline Mutations

  NCT07218575· Phase 2/3· Boston Children's Hospital· Source

• Recruiting

  Advocacy, Partnership, Outreach, and Yielding Optimized Care for Oncology Patients

  NCT07403981· Stanford University· Source

• Not yet recruiting

  Study of a 1-Millimeter Resolution Clinical Positron Emission Tomography (PET) System in Head and Neck Cancer Imaging

  NCT04662554· Stanford University· Source

• Not yet recruiting

  A Pilot Study of Anselamimab in Patients With AL Amyloidoma and Measurable Tissue Involvement

  NCT07615270· Early phase 1· Stanford University· Source

• Recruiting

  Using Continuous Glucose Monitoring to Quantify the Effects of NOURISH's Culturally Modified Meals on Asian Americans With Type 2 Diabetes

  NCT06836479· Stanford University· Source

• Recruiting

  Trial Comparing LATTICE Radiotherapy vs Moderately Dose-escalated Palliative Radiation for Patients With Metastases.

  NCT07594431· Phase 2· Stanford University· Source

• Recruiting

  Study of Intrathecal ELP-02 for Charcot-Marie-Tooth Disease Type 4J (CMT4J)

  NCT07447557· Phase 1/2· Elpida Therapeutics SPC· Source

• Not yet recruiting

  Sonication-based OCD Neurosurgical Intervention Via Capsulotomy

  NCT06131502· Phase 1/2· Brigham and Women's Hospital· Source

• Recruiting

  Dose-Escalation Study of Artesunate Patients With IPF

  NCT05988463· Phase 1· Joseph C. Wu· Source

• Enrolling by invitation

  Simultaneous Measurement of EpicArdial and Microvascular ResisTance Via Angiographic FLOW Study

  NCT07676097· AngioInsight· Source

• Recruiting

  A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

  NCT07497087· Phase 3· Boehringer Ingelheim· Source

• Recruiting

  TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT

  NCT07302776· Phase 1· Stanford University· Source

• Recruiting

  GBPDC: Gut-Brain in PD Consortium Master Protocol

  NCT07567794· Duke University· Source

• Not yet recruiting

  A Pilot Study Using Gut-Directed Hypnotherapy for Hospitalized Patients

  NCT07676136· Stanford University· Source

• Not yet recruiting

  Study of Psilocybin Under Anesthesia Controlled by EEG

  NCT07479550· Phase 2· Stanford University· Source

• Not yet recruiting

  Targeting Collagen VII Antibodies in Bullous Diseases Using Efgartigimod IV (VYVGART)

  NCT07011589· Phase 1/2· M. Peter Marinkovich· Source

• Not yet recruiting

  Tiprelestat Versus Placebo When Added to Standard of Care for the Treatment of Pulmonary Arterial Hypertension (PAH)

  NCT07601295· Phase 2· Stanford University· Source

• Not yet recruiting

  Feasibility Study of a Continuous Glucose-Ketone Monitoring Device in People With Type 1 Diabetes

  NCT06977633· Mahla Poudineh· Source

• Recruiting

  Trial of an Online Spanish Pivotal Response Treatment Training in Autism Spectrum Disorder

  NCT06690255· Stanford University· Source

• Recruiting

  Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

  NCT07504458· Phase 3· Quetzal Therapeutics· Source

• Not yet recruiting

  Light and Sleep Fragmentation

  NCT06009289· Phase 4· Stanford University· Source

• Not yet recruiting

  Early Brainwave Biomarkers for Personalized Neuromodulation in Treatment-resistant Depression

  NCT07528157· Stanford University· Source

• Recruiting

  Preoperative Hemodialysis Timing in Patients With End-Stage Kidney Disease: The POD-ESKD Pilot Trial

  NCT07339202· Stanford University· Source

• Recruiting

  Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

  NCT07326566· Phase 2· Black Diamond Therapeutics, Inc.· Source

• Active, not recruiting

  Vital Signs Blood Pressure Trial

  NCT06272318· Stanford University· Source

• Recruiting

  A First-in-Patient Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease

  NCT07377565· Phase 1· Nielsen Fernandez-Becker· Source

• Recruiting

  A Phase 1 Safety and Dose Finding Study of GLIX1 in Adults With Recurrent or Progressive High-grade Glioma

  NCT07464925· Phase 1· Tetragon Biosciences Ltd· Source

Showing 50 of 370.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers22 recruiting
• Autism19 recruiting
• Acute myeloid leukaemia10 recruiting
• Depression10 recruiting
• Lung cancer10 recruiting
• Parkinson disease10 recruiting
• Type 1 diabetes9 recruiting
• Heart failure8 recruiting
• Head and neck cancer7 recruiting
• Stroke7 recruiting
• Alzheimer disease6 recruiting
• Atrial fibrillation6 recruiting
• Epidermolysis bullosa6 recruiting
• Obesity6 recruiting
• Sarcoma6 recruiting
• Type 2 diabetes6 recruiting
• Acute lymphoblastic leukaemia5 recruiting
• Colorectal cancer5 recruiting
• Epilepsy5 recruiting
• Ovarian cancer5 recruiting
• Pancreatic cancer5 recruiting
• ALS (motor neurone disease)4 recruiting
• Amyloidosis4 recruiting
• Aortic aneurysm4 recruiting
• Coronary artery disease4 recruiting
• Cystic fibrosis4 recruiting
• Dermatomyositis and polymyositis (myositis)4 recruiting
• Gastric and oesophageal cancer4 recruiting
• High blood pressure4 recruiting
• Liver and biliary tract cancer4 recruiting
• Mesothelioma4 recruiting
• Myelodysplastic syndromes4 recruiting
• Prostate cancer4 recruiting
• Schizophrenia4 recruiting
• Spinal cord injury4 recruiting
• Bladder cancer3 recruiting
• Charcot-Marie-Tooth disease3 recruiting
• Chronic kidney disease3 recruiting
• Duchenne muscular dystrophy3 recruiting
• Glioblastoma3 recruiting
• Idiopathic pulmonary fibrosis3 recruiting
• Irritable bowel syndrome3 recruiting
• Lewy body dementia3 recruiting
• Mantle cell lymphoma3 recruiting
• Multiple myeloma3 recruiting
• Myeloproliferative neoplasms3 recruiting
• Postural tachycardia syndrome (POTS)3 recruiting
• Pulmonary arterial hypertension3 recruiting
• Systemic sclerosis (scleroderma)3 recruiting
• Aplastic anaemia2 recruiting
• Brain metastases2 recruiting
• Chronic myeloid leukaemia2 recruiting
• Congenital heart disease2 recruiting
• Diffuse large B-cell lymphoma2 recruiting
• Frontotemporal dementia2 recruiting
• Kidney cancer2 recruiting
• Melanoma2 recruiting
• Mild cognitive impairment2 recruiting
• Multiple sclerosis2 recruiting
• Multiple system atrophy2 recruiting
• Myotonic dystrophy2 recruiting
• Neuroblastoma2 recruiting
• Neurofibromatosis type 12 recruiting
• Osteoarthritis2 recruiting
• Triple-negative breast cancer2 recruiting
• Ulcerative colitis2 recruiting
• Aortic stenosis1 recruiting
• Asthma1 recruiting
• Bipolar disorder1 recruiting
• Burkitt lymphoma1 recruiting
• Cervical cancer1 recruiting
• Coeliac disease1 recruiting
• COPD1 recruiting
• Crohn's disease1 recruiting
• Deep vein thrombosis and pulmonary embolism1 recruiting
• Diabetic neuropathy1 recruiting
• Endometrial cancer1 recruiting
• Fatty liver disease (MASLD/MASH)1 recruiting
• Fibromyalgia1 recruiting
• Follicular lymphoma1 recruiting
• Haemophilia1 recruiting
• Hearing loss1 recruiting
• Hepatitis B1 recruiting
• Hodgkin lymphoma1 recruiting
• Huntington's disease1 recruiting
• Immune thrombocytopenia (ITP)1 recruiting
• Insomnia1 recruiting
• Liver cirrhosis1 recruiting
• Lupus (SLE)1 recruiting
• Migraine1 recruiting
• Narcolepsy1 recruiting
• Nephrotic syndrome1 recruiting
• Neuroendocrine tumours1 recruiting
• Osteonecrosis (avascular necrosis)1 recruiting
• Primary biliary cholangitis1 recruiting
• Restless legs syndrome1 recruiting
• Sarcoidosis1 recruiting
• Spinal muscular atrophy1 recruiting
• Testicular cancer1 recruiting
• Thalassaemia1 recruiting
• Thymoma and thymic carcinoma1 recruiting
• Uterine fibroids1 recruiting

Closed trials

• Completed

  Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type 1 Diabetes

  NCT07325461· Tandem Diabetes Care, Inc.· Source

• Completed

  The BEAR Program for Women With Trauma Who Have Suicidal Thoughts

  NCT07346638· Stanford University· Source

• Recruiting

  A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder

  NCT06793397· Phase 3· Cybin IRL Limited· Source

• Completed

  Subcutaneous Pharmacokinetic Evaluation of Monomeric Insulin and Lyumjev in Adults With Type 1 Diabetes

  NCT07090824· Phase 1· Stanford University· Source

• Completed

  BEAD-T1D: Building the Evidence to Address Disengagement in Type 1 Diabetes

  NCT05488119· Stanford University· Source

• Completed

  A First-in-human Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease

  NCT07063823· Phase 1· Nielsen Fernandez-Becker· Source

• Withdrawn

  Augmented Reality-based Telerehabilitation Platform for Patients With Stroke

  NCT06963645· Stanford University· Source

• Completed

  NE3107 in Adults With Neurological Symptoms of Long COVID

  NCT06847191· Phase 2· BioVie Inc.· Source

• Completed

  A Study of ONO-2020 in Participants With Mild to Moderate Alzheimer's Disease

  NCT06881836· Phase 2· Ono Pharmaceutical Co., Ltd.· Source

• Withdrawn

  Prediabetes Stratification by Multi-omics Profile After Food Intake

  NCT06005051· Stanford University· Source

• Completed

  Assessment of Novel Metabolic Imaging Modalities as A Predictor Of Therapeutic EfficacyiIn Glioblastoma (GBM)

  NCT06855628· Phase 2· Stanford University· Source

• Completed

  A Prospective Cohort Study to Assess Clinical Effectiveness of an Investigational Digital Therapeutic (CT-155) in Patients With Experiential Negative Symptoms of Schizophrenia

  NCT06791122· Boehringer Ingelheim· Source

• Completed

  Automated Insulin Delivery for Inpatients With Dysglycemia

  NCT06418880· Phase 3· Emory University· Source

• Withdrawn

  Genicular Artery Embolization (GAE) for Osteoarthritic Knee Pain

  NCT04472091· Andrew Picel· Source

• Completed

  Reliability of the Samsung Galaxy for the Detection of Moderate to Severe Obstructive Sleep Apnea

  NCT06603441· Stanford University· Source

• Completed

  Study of Natriuretic Peptide Receptor 1 (NPR1) Antagonist in Adult Patients With Postural Orthostatic Tachycardia Syndrome (POTS)

  NCT06593600· Phase 2· Regeneron Pharmaceuticals· Source

• Completed

  Safety Evaluation of MiniMed™ 780G System With DS5 CGM in Children

  NCT06604871· Medtronic MiniMed, Inc.· Source

• Completed

  Food Is Medicine for Patients With Heart Failure

  NCT06540118· University of California, San Diego· Source

• Terminated

  ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension

  NCT06418711· Phase 3· Mannkind Corporation· Source

• Completed

  RECOVER-SLEEP: Platform Protocol

  NCT06404086· Phase 2· Duke University· Source

• Completed

  RECOVER-ENERGIZE Platform Protocol

  NCT06404047· Duke University· Source

• Withdrawn

  Sirolimus for Improving Social Abilities in People With PTEN Germline Mutations

  NCT06080165· Phase 1/2· Stanford University· Source

• Completed

  Efficacy of the Dreem 3S Ambulatory Sleep Monitoring Device for the Evaluation of Narcolepsy

  NCT06531876· Beacon Biosignals· Source

• Completed

  Engagement and Clinical Impact of the Teleo Virtual Therapy Platform in Clinical Settings

  NCT06364137· Stanford University· Source

• Completed

  A Study To Evaluate The Safety Of CMTX-101 In People With Cystic Fibrosis

  NCT06159725· Phase 1/2· Clarametyx Biosciences, Inc.· Source

• Recruiting

  AMT-260 Gene Therapy Study in Adults With Unilateral Refractory Mesial Temporal Lobe Epilepsy

  NCT06063850· Phase 1/2· UniQure Biopharma B.V.· Source

• Completed

  Global Study of Del-desiran for the Treatment of DM1

  NCT06411288· Phase 3· Avidity Biosciences, Inc.· Source

• Completed

  Investigational Extended Wear Insulin Infusion Set in People With Type 1 Diabetes

  NCT06273124· Tandem Diabetes Care, Inc.· Source

• Terminated

  Fluorescent Probe VGT-309 to ID Cancerous Colorectal Lesions During Augmented Colonoscopy

  NCT06034197· Early phase 1· Stephan Rogalla· Source

• Withdrawn

  Accelerated Intermittent Theta-Burst Stimulation for Opiate Use Disorder

  NCT03804619· Stanford University· Source

• Completed

  Safety, Tolerability, PK, and PD Study of PGN-EDODM1 in Participants With Myotonic Dystrophy Type 1

  NCT06204809· Phase 1· PepGen Inc· Source

• Completed

  Behavioral and Neuronal Correlates of Human Mood States

  NCT06159595· Stanford University· Source

• Completed

  The Pediatric Artificial Pancreas Automated Initialization Trial

  NCT06017089· Marc Breton· Source

• Terminated

  STOP-T1D Low-Dose (ATG)

  NCT04291703· Phase 2· National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)· Source

• Completed

  Spark: Finding the Optimal Tracking Strategy for Weight Loss in a Digital Health Intervention

  NCT05249465· Stanford University· Source

• Completed

  Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC)

  NCT06060665· Phase 3· Gilead Sciences· Source

• Completed

  RECOVER-NEURO: Platform Protocol to Measure the Effects of Cognitive Dysfunction Interventions on Long COVID Symptoms

  NCT05965752· Duke University· Source

• Completed

  Clinician Training Program to Integrate Digital CBTI Into Routine Psychotherapy

  NCT05814783· Stanford University· Source

• Completed

  Mobile & Online-Based Interventions to Lessen Pain

  NCT05152134· Phase 3· Stanford University· Source

• Completed

  Improving Glycemic Control Using a Virtual Weight Control Program and Continuous Glucose Monitoring

  NCT05935514· Pennington Biomedical Research Center· Source

• Completed

  Empowered Relief for Youth

  NCT05998369· Stanford University· Source

• Completed

  RECOVER-VITAL: Platform Protocol to Measure the Effects of Antiviral Therapies on Long COVID Symptoms

  NCT05595369· Phase 2· Kanecia Obie Zimmerman· Source

• Completed

  Investigating Two rTMS Strategies to Treat Cannabis Use Disorder

  NCT05720312· Stanford University· Source

• Terminated

  64Cu-SAR-BBN and 67CU SAR-BBN for Identification and Treatment of Gastrin Releasing Peptide Receptor (GRPR)-Expressing Metastatic Castrate Resistant Prostate Cancer in Patients Who Are Ineligible for Therapy With 177Lu-PSMA-617 (COMBAT)

  NCT05633160· Phase 1/2· Clarity Pharmaceuticals Ltd· Source

• Completed

  Evaluating a Type 2 Diabetes Prevention Program

  NCT05822648· Stanford University· Source

• Completed

  PrehabPal: A Digital Tool to Help Older Adults Prepare for Cancer Surgery

  NCT05520866· University of California, San Francisco· Source

• Withdrawn

  Study Evaluating the Safety, Tolerability, and Efficacy of FLT3 CAR-T AMG 553 in FLT3-positive Relapsed/Refractory AML

  NCT03904069· Phase 1· Amgen· Source

• Completed

  The BEAR Therapeutic Program for Women

  NCT04418778· Stanford University· Source

• Withdrawn

  INCAGN01876 in Combination With Immunotherapy in Participants With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

  NCT05359692· Phase 2· Incyte Biosciences International Sàrl· Source

• Completed

  A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Of AJ201 In Patients

  NCT05517603· Phase 1/2· AnnJi Pharmaceutical Co., Ltd.· Source

Showing 50 of 180.

Conditions

Diseases this institution publishes on or runs trials for.

• Stroke378 works · 12 trials
• Heart failure349 works · 11 trials
• Alzheimer disease345 works · 14 trials
• Obesity286 works · 11 trials
• Lung cancer208 works · 21 trials
• Type 2 diabetes146 works · 16 trials
• Melanoma142 works · 6 trials
• Atrial fibrillation134 works · 7 trials
• Glioblastoma125 works · 8 trials
• Liver and biliary tract cancer123 works · 10 trials
• HIV121 works · 0 trials
• Parkinson disease118 works · 12 trials
• Coronary artery disease116 works · 11 trials
• Chronic kidney disease110 works · 5 trials
• Epilepsy102 works · 16 trials
• Osteoarthritis100 works · 6 trials
• Type 1 diabetes94 works · 29 trials
• Prostate cancer93 works · 13 trials
• Depression89 works · 23 trials
• Colorectal cancer89 works · 13 trials
• Sarcoma78 works · 8 trials
• Congenital heart disease75 works · 4 trials
• Asthma72 works · 1 trial
• Mild cognitive impairment69 works · 5 trials
• Ovarian cancer69 works · 6 trials
• Glaucoma67 works · 0 trials
• Acute myeloid leukaemia65 works · 18 trials
• Insomnia64 works · 3 trials
• Bladder cancer63 works · 8 trials
• Multiple sclerosis62 works · 6 trials